Telix Pharmaceuticals Statistics
Total Valuation
ASX:TLX has a market cap or net worth of AUD 3.46 billion. The enterprise value is 3.78 billion.
| Market Cap | 3.46B |
| Enterprise Value | 3.78B |
Important Dates
The last earnings date was Monday, January 19, 2026.
| Earnings Date | Jan 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:TLX has 338.76 million shares outstanding. The number of shares has decreased by -37.99% in one year.
| Current Share Class | 338.76M |
| Shares Outstanding | 338.76M |
| Shares Change (YoY) | -37.99% |
| Shares Change (QoQ) | -4.06% |
| Owned by Insiders (%) | 14.87% |
| Owned by Institutions (%) | 37.94% |
| Float | 275.69M |
Valuation Ratios
The trailing PE ratio is 156.98 and the forward PE ratio is 618.19. ASX:TLX's PEG ratio is 37.86.
| PE Ratio | 156.98 |
| Forward PE | 618.19 |
| PS Ratio | 3.41 |
| PB Ratio | 5.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 235.31 |
| P/OCF Ratio | 100.22 |
| PEG Ratio | 37.86 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 61.76, with an EV/FCF ratio of 257.22.
| EV / Earnings | 228.57 |
| EV / Sales | 3.73 |
| EV / EBITDA | 61.76 |
| EV / EBIT | 88.22 |
| EV / FCF | 257.22 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.99.
| Current Ratio | 1.33 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | 10.42 |
| Debt / FCF | 43.40 |
| Interest Coverage | 2.64 |
Financial Efficiency
Return on equity (ROE) is 3.14% and return on invested capital (ROIC) is 4.44%.
| Return on Equity (ROE) | 3.14% |
| Return on Assets (ROA) | 2.08% |
| Return on Invested Capital (ROIC) | 4.44% |
| Return on Capital Employed (ROCE) | 3.15% |
| Weighted Average Cost of Capital (WACC) | 9.25% |
| Revenue Per Employee | 2.40M |
| Profits Per Employee | 39,104 |
| Employee Count | 431 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 10.97 |
Taxes
| Income Tax | -2.75M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.20% in the last 52 weeks. The beta is 1.15, so ASX:TLX's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | -65.20% |
| 50-Day Moving Average | 12.42 |
| 200-Day Moving Average | 18.29 |
| Relative Strength Index (RSI) | 34.26 |
| Average Volume (20 Days) | 2,848,605 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:TLX had revenue of AUD 1.01 billion and earned 16.54 million in profits. Earnings per share was 0.07.
| Revenue | 1.01B |
| Gross Profit | 546.48M |
| Operating Income | 42.86M |
| Pretax Income | 13.79M |
| Net Income | 16.54M |
| EBITDA | 55.53M |
| EBIT | 42.86M |
| Earnings Per Share (EPS) | 0.07 |
Balance Sheet
The company has 315.98 million in cash and 637.96 million in debt, with a net cash position of -321.99 million or -0.95 per share.
| Cash & Cash Equivalents | 315.98M |
| Total Debt | 637.96M |
| Net Cash | -321.99M |
| Net Cash Per Share | -0.95 |
| Equity (Book Value) | 643.59M |
| Book Value Per Share | 1.90 |
| Working Capital | 151.66M |
Cash Flow
In the last 12 months, operating cash flow was 34.51 million and capital expenditures -19.81 million, giving a free cash flow of 14.70 million.
| Operating Cash Flow | 34.51M |
| Capital Expenditures | -19.81M |
| Free Cash Flow | 14.70M |
| FCF Per Share | 0.04 |
Margins
Gross margin is 53.94%, with operating and profit margins of 4.23% and 1.63%.
| Gross Margin | 53.94% |
| Operating Margin | 4.23% |
| Pretax Margin | 1.36% |
| Profit Margin | 1.63% |
| EBITDA Margin | 5.48% |
| EBIT Margin | 4.23% |
| FCF Margin | 1.45% |
Dividends & Yields
ASX:TLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 37.99% |
| Shareholder Yield | 37.99% |
| Earnings Yield | 0.48% |
| FCF Yield | 0.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:TLX has an Altman Z-Score of 4.57 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.57 |
| Piotroski F-Score | 4 |